|
Juvenile-Onset Still Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Juvenile arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Juvenile psoriatic arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.
|
22960999 |
2012 |
|
Adult Liver Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
|
31783876 |
2019 |
|
Adult Liver Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
It has been reported that long noncoding RNA (lncRNA) DILC inhibited IL-6 to regulate liver cancer stem cells.
|
31069838 |
2019 |
|
Adult Liver Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
IL-6 produced by human fibroblast-like synoviocytes (HFLS) promotes rheumatoid arthritis (RA), while lncRNA DILC regulates liver cancer stem cells by inhibiting IL-6.
|
30944206 |
2019 |
|
Adult Liver Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our previous studies showed that lnc-DILC was an important tumor suppressor gene in both liver cancer and colorectal cancer.
|
31176734 |
2019 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
It has been reported that long noncoding RNA (lncRNA) DILC inhibited IL-6 to regulate liver cancer stem cells.
|
31069838 |
2019 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
|
31783876 |
2019 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our previous studies showed that lnc-DILC was an important tumor suppressor gene in both liver cancer and colorectal cancer.
|
31176734 |
2019 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
IL-6 produced by human fibroblast-like synoviocytes (HFLS) promotes rheumatoid arthritis (RA), while lncRNA DILC regulates liver cancer stem cells by inhibiting IL-6.
|
30944206 |
2019 |
|
Malignant neoplasm of liver
|
0.050 |
Biomarker
|
disease |
BEFREE |
IL-6 produced by human fibroblast-like synoviocytes (HFLS) promotes rheumatoid arthritis (RA), while lncRNA DILC regulates liver cancer stem cells by inhibiting IL-6.
|
30944206 |
2019 |
|
Malignant neoplasm of liver
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
|
31783876 |
2019 |
|
Malignant neoplasm of liver
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our previous studies showed that lnc-DILC was an important tumor suppressor gene in both liver cancer and colorectal cancer.
|
31176734 |
2019 |
|
Malignant neoplasm of liver
|
0.050 |
Biomarker
|
disease |
BEFREE |
It has been reported that long noncoding RNA (lncRNA) DILC inhibited IL-6 to regulate liver cancer stem cells.
|
31069838 |
2019 |
|
Adult Liver Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
|
26812074 |
2016 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
|
26812074 |
2016 |
|
Malignant neoplasm of liver
|
0.050 |
Biomarker
|
disease |
BEFREE |
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
|
26812074 |
2016 |
|
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Our previous studies showed that lnc-DILC was an important tumor suppressor gene in both liver cancer and colorectal cancer.
|
31176734 |
2019 |
|
Colorectal Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
ROC analyses showed that lnc-DILC levels were reliable in distinguishing patients with CRC from normal colorectal tissues.
|
31081085 |
2019 |